Skip to content
DGX Quest Diagnostics Inc NYSE
134.62 USD -0.77% -1.05
OPEN 135.60
DAY RANGE 135.60 - 134.24
VOLUME 45213
52 WEEK RANGE 158.34 - 120.40
Interactive Brokers Logotype

Buy DGX stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 15.2B
Enterprise value 19.5B
Trailing pe 19.863836
Forward pe 14.908791
Peg ratio 14.908791
Price to sales ttm 1.5824492
Price to book mrq 2.5115702
Enterprise to revenue 2.028
Enterprise to ebitda 10.887


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.08258
Operating margin 0.14069
Return on assets ttm 0.06437
Return on equity ttm 0.13572
Income statement
Revenue ttm 9.6B
Revenue per share ttm 84.053
Quarterly revenue growth -0.107
Gross profit ttm 3.5B
Ebitda 1.6B
Net income to common ttm 789M
Diluted eps ttm 6.83
Quarterly earnings growth yoy -0.431
Balance sheet
Total cash mrq 175M
Total cash per share mrq 1.562
Total debt mrq 4.6B
Total debt to equity mrq 74.972
Current ratio mrq 1.339
Book value per share mrq 54.018
Cash flow
Operating cash flow ttm 1.3B
Levered free cash flow ttm 554.9M

Stock statistics

Shares outstanding 112M
Float shares 111M
Avg 10 volume 1.1M
Avg 30 volume 1M
Shares short 4.1M
Short ratio 3.78
Short percent of shares outstanding 0.0478
Percent held by insiders 0.0083099995
Percent held by institutions 0.92971003

Stock price summary

Fifty two week low 120.4
Fifty two week high 158.34
Fifty two week change 2.438
Beta 0.939479
Day 50 ma 137.7192
Day 200 ma 139.5389

Dividends and splits

Forward annual dividend rate 2.84
Forward annual dividend yield 0.021300001
Trailing annual dividend rate 2.69
Trailing annual dividend yield 0.019940699
5 year average dividend yield 1.9
Payout ratio 0.3939
Dividend date 2023-07-25
Ex dividend date 2023-07-10
Last split factor 2-for-1 split
Last split date 2005-06-21

Quest Diagnostics (DGX) company profile

Quest Diagnostics (NYSE: DGX) is an independent provider of diagnostic testing, information, and services. The company engages in clinical testing, anatomic pathology, esoteric testing, and substance abuse testing. It operates through the segments of Diagnostic Information Services and Diagnostic Solutions.